Topical Cannabidiol for Treating Carpal Tunnel Syndrome

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

July 1, 2025

Primary Completion Date

December 1, 2026

Study Completion Date

January 1, 2027

Conditions
Carpal Tunnel Syndrome
Interventions
DRUG

Cannabidiol

Cannabidiol (CBD) is a non-psychoactive minor cannabinoid component of Cannabis sativa that is emerging as a treatment to mitigate pain, numbness, and tingling associated with peripheral neuropathy. CBD acts through multiple receptors to modulate central and peripheral neuropathic signaling pathways to alleviate pain.

All Listed Sponsors
lead

University of Virginia

OTHER